Analyst Report

Predicts 2024: Generative AI Brings New Value to Life Sciences

View the report

Step into the future of life sciences with Generative AI, where the power of advanced analytics and AI-driven innovations is already changing the landscape of drug discovery and development. Gain practical strategies for leveraging the AI revolution, boosting efficiency, and fostering sustainable growth amid digital advancements. Discover how cutting-edge AI and commitment to sustainability can transform obstacles into strategic advantages for your business.

“By 2026, investment in experimental and computational lab integration and translational capabilities will double, due to subpar real-world performance of AI-generated drugs.”

Don’t wait, get access to this report now before it’s too late!


View the report

Ennov may use your contact information to provide updates and special offers about Ennov products and services.

EPredicts 2024: Generative AI Brings New Value to Life Sciences Published 10 January 2024. By Analyst(s): Reuben Harwood, Animesh Gandhi, Michael Shanler, Jeff Smith

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.